Further reading

We’ve compiled a list of resources for those who want to dedicate more time and continue to explore antibiotic resistance. At the bottom of this page, you’ll also find a reference list of this course.

Organisations/Associations

World Health Organization (WHO)

European Centre for Disease Prevention and Control (ECDC)

Centers for Disease Control and Prevention (CDC)

Center for Disease Dynamics, Economics & Policy (CDDEP)

World Organisation for Animal Health (OIE)

Food and Agriculture Organization of the United Nations (FAO)

Action on Antibiotic Resistance (ReAct)

Reports

Tackling Drug-Resistant Infections Globally: final report and recommendations by AMR Review (2016)

National Action Plan for Combating Antibiotic-Resistant Bacteria by the White House (2015)

Global Action Plan on Antimicrobial Resistance by WHO (2015)

Worldwide Country Situation Analysis: Response to Antimicrobial Resistance by WHO (2015)

Antibiotic Resistance: Multi-country public awareness survey by WHO (2015)

Antimicrobial Resistance: Global Report on Surveillance by WHO (2014)

New Business Models for Sustainable Antibiotics by Chatham House (2014)

Antibiotic Resistance Threats in the United States by CDC (2013)

Journals/Articles

Hassing RJ, Alsma J, Arcilla MS, van Genderen PJ, Stricker BH, Verbon A. International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review. Euro Surveill. 2015;20(47).

Heyman G, Cars O, Bejarano MT, Peterson S. Access, excess, and ethics – towards a sustainable distribution model for antibiotics. Ups J Med Sci. 2014 May;119(2):134-141.

Hughes D, Karlén A. Discovery and preclinical development of new antibiotics. Ups J Med Sci. 2014 May; 119(2):162-169.

Jasovsky D, Littmann J, Zorzet A, Cars C. Antimicrobial Resistance – A Threat to the World’s Sustainable Development. Development dialogue paper, no 16, 2016.

Tängdén T, Adler M, Cars O, Sandegren L, Löwdin E. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. J Antimicrob Chemother. 2013 Jun;68(6):1319-1326.